Breaking News: Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce the appointment of Dr. Patricio Stocker, the former Chief Executive Officer of PharmaCielo Ltd. (TSXV: PCLO) as Chief Executive Officer of the Company. Mr. Christian Toro has been appointed as Executive Chairman of the Board.

Dr. Stocker is an accomplished executive with extensive international experience having led the successful development of numerous companies, including most recently PharmaCielo Ltd. (“PharmaCielo”), a leading Colombian producer of medicinal cannabis. Dr. Stocker joined PharmaCielo in 2015 and served as CEO through 2018. During his tenure of as CEO, Dr. Stocker was instrumental in the development of corporate strategies, formation of strategic relationships, the cannablis licensing process and capital raising initiatives. Dr. Stocker was also actively involved in the development of PharmaCielo’s Colombian operations to establish a scalable and competitive cultivation and oil production strategy.

“Dr. Stocker has a proven track record of growing emerging businesses, combined with extensive expertise in the cannabis industry and capital markets. The board of directors is confident that his skillset and experience make him an ideal leader for the company as we continue to scale our operations rapidly and execute on our global growth strategy” stated Christian Toro, Executive Chairman.  

Dr. Stocker stated “I have been very impressed with Blueberries on a number of fronts. Their team, relationships, facilities and strategy are unique and have positioned the Company to become a dominant player in the Latin American and global cannabis markets. I am looking forward to leading Blueberries as we continue to execute on a domestic and international business plan.”

Dr. Stocker is fluent in English, Spanish, German and Portuguese. He also holds a PhD in Economics and B.A. in Business Administration from the University of St. Gallen in Switzerland. Prior to his role as CEO of PharmaCielo, Dr. Stocker held top management positions in the automotive industry, including service on the board of directors of multinational corporations.

The Company has granted 1,000,000 compensation shares to Dr. Stocker as well as options (the “Options”) to purchase up to 3,000,000 common shares in the capital of the Company, pursuant to the Company’s stock option plan. The Company has also granted 100,000 Options to advisors of the Company pursuant to the Company’s stock option plan. The Options are exercisable at a price of $0.55 per share.

About Blueberries Medical Corp.
Blueberries is a Colombia-based licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia. Led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

[popuppress id=”203144″]

1 Comment
  1. Trent Miller 4 years ago

    this is huge, $PCLO is up almost 100% in a month.

Leave a Comment